
Julie R Gralow MD
Hematologic Oncology
Chief Medical Officer, American Society of Clinical Oncology (ASCO)
Join to View Full Profile
2318 Mill Road suite 800Alexandria, VA 22314
Phone+1 571-483-1650
Dr. Gralow is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 1992 - 1995
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 1989 - 1991
Mass General Brigham/Brigham and Women's HospitalInternship, Internal Medicine, 1988 - 1989
Keck School of Medicine of the University of Southern CaliforniaClass of 1988
Stanford UniversityBS, Biology, 1977 - 1981
Certifications & Licensure
WA State Medical License 1992 - 2027
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Humanitarian Award ASCO, 2018
- America's Top Doctors Castle Connolly, 2008-2018
- America's Top Doctors for Cancer Castle Connolly, 2007-2018
Clinical Trials
- Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast Cancer Start of enrollment: 2001 Jan 01
- S0102: Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer Start of enrollment: 2001 May 01
- Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer Start of enrollment: 2001 Sep 01
Publications & Presentations
PubMed
- The Pathologic Response Evaluation and Detection in Circulating Tumor-DNA Study: Ultrasensitive Circulating Tumor-DNA Assessment of Breast Cancer Minimal Residual Dise...Natasha B Hunter, Heather A Parsons, Leslie Cope, Jenna V Canzoniero, Fabio C P Navarro
Journal of Clinical Oncology. 2026-05-10 - International comparisons of survival after recurrent metastatic breast cancer in four countries: A population-based study.Hanna Fink, Isabelle Soerjomataram, Aude Bardot, Aline Brennan, Ryan R Woods
Breast. 2026-04-02 - Long-term follow-up of S0221, comparing alternative dose-schedules of anthracycline and taxane therapy in early breast cancer.Azka Ali, William E Barlow, Halle C F Moore, Timothy J Hobday, Claudine Isaacs
JNCI Cancer Spectrum. 2026-03-03
Journal Articles
- Final Analysis of the Prevention of Early Menopause Study (POEMS)/SWOG Intergroup S0230Carol J Fabian, Julie R Gralow, Journal of the National Cancer Institute
- Functional Decline and Resilience in Older Women Receiving Adjuvant Chemotherapy for Breast CancerAminah Jatoi, Antonio C Wolff, Harvey Jay Cohen, Rachel A Freedman, Gustav Magrinat, Julie Gralow, Gretchen Kimmick, Heidi D Klepin, Harold Burstein, Hyman Muss, Jeann..., Journal of the American Geriatrics Society
- Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemothe...Albain KS, Barlow WE, Shak S, Hortobagyi GN, Livingston RB, Yeh IT, Ravdin P, Bugarini R, Baehner FL, Davidson NE, Sledge GW, Winer EP, Hudis C, Ingle JN, Perez EA, Pr..., Lancet Oncol
Books/Book Chapters
Abstracts/Posters
- Spontaneous and Induced Immunoglobulin Secretion and Differentiation in Human B-Cell Lymphomas and Leukemias.Gralow J, Levy R, Miller RA, Federation Proceedings, Federation of American Societies for Experimental Biology
- Southern Blotting of DNA from Formalin-Fixed, Paraffin Embedded Tissue.Dubeau L, Chandler L, Gralow J, Nichols PW, Jones PA, International Academy of Pathology
- Recovery of Intact, High Molecular Weight DNA from Formalin-Fixed, Paraffin Embedded Pathology Specimens.Dubeau L, Chandler L, Gralow J, Nichols PW, Jones PA, American Urological Association
Authored Content
- ASCO GU 2023 Highlights with Dr. Julie GralowFebruary 2023
- Milestones and New Research from ASCO GI 2023January 2023
Press Mentions
U.S. Oncology Drug Supply Remains Stable Amid Ongoing Conflict in the Middle East U.S. Oncology Drug Supply Remains Stable Amid Ongoing Conflict in the Middle EastApril 13th, 2026
Kennedy Sidelining of US Advisory Panel Delays Updates to Cancer Screening GuidelinesApril 2nd, 2026
Why Some Doctors Say There Are Cancers That Shouldn’t Be TreatedDecember 8th, 2025
Grant Support
- ClinicalNational Cancer Institute2010–2011
- Breast Cancer Tumor BankNational Cancer Institute1995–1996
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









